Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$63.92T
24h Vol:
$4.36B
Dominance:
MSFT:4.92%
Stocklytics Platform
Instrument logo  QDEL
Quidel Corp
QDEL
58 / 100
$42.45arrow_drop_down1.23%-$0.53

Performance History

Stocklytics logo
Key Stats
Open$42.62
Prev. Close$42.98
EPS-0.15
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.94B
PE Ratio-
LOWHIGH
Day Range42.31
43.10
52 Week Range41.75
98.67
Ratios
P/B Ratio0.57
Revenue-
Operating M. %13.49%
Earnings$0.00
Earnings Growth %-101.84%
EBITDA Margin %24.59%
ROE %-0.20%
EPS-0.15

Score Breakdown

58vs 55. Market Avg.

All Score 58 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

QDELMARKET
Value5940
Quality5540
Ownership317
Growth4145
Dividends-38
check_circle

Quidel Corp's Price discount from 1 year high of 54.92% is great compared to market average of 18.05%. This indicates QDEL could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$751.62
24H (%)arrow_drop_down1.04%
24H ($)-$7.97
MARKET CAP$724.46B
PRICE$438.91
24H (%)arrow_drop_down0.63%
24H ($)-$2.81
MARKET CAP$414.91B
PRICE$147.57
24H (%)arrow_drop_down0.81%
24H ($)-$1.21
MARKET CAP$361.94B
PRICE$126.33
24H (%)arrow_drop_up0.14%
24H ($)$0.18
MARKET CAP$321.01B

About Quidel Corp (QDEL)

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Douglas C. Bryant
Headquarters
San Diego
Employees
7000
Exchange
NASDAQ
add Quidel Corp to watchlist

Keep an eye on Quidel Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Quidel Corp's (QDEL) price per share?

The current price per share for Quidel Corp (QDEL) is $42.45. The stock has seen a price change of -$0.53 recently, indicating a -1.23% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Quidel Corp (QDEL)?

For Quidel Corp (QDEL), the 52-week high is $98.67, which is 132.44% from the current price. The 52-week low is $41.75, the current price is 1.68% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Quidel Corp (QDEL) a growth stock?

Quidel Corp (QDEL) has shown an average price growth of -28.68% over the past three years. It has received a score of 19 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Quidel Corp as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Quidel Corp (QDEL) stock price performance year to date (YTD)?

As of the latest data, Quidel Corp (QDEL) has a year-to-date price change of -43.18%. Over the past month, the stock has experienced a price change of -10.14%. Over the last three months, the change has been -41.83%. Over the past six months, the figure is -37.59%. Looking at a longer horizon, the five-year price change stands at -34.02%.

help
Is Quidel Corp (QDEL) a profitable company?

Quidel Corp (QDEL) has a net income of -$10.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 42.87% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.49% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $1.28B. Operating income is noted at $246.3M. Furthermore, the EBITDA is $691.3M.

help
What is the market capitalization of Quidel Corp (QDEL)?

Quidel Corp (QDEL) has a market capitalization of $2.94B. The average daily trading volume is 966.47K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.